Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation

Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation

Activation of synovial fibroblasts (SFs) contributes to rheumatoid arthritis (RA) by damaging synovial membranes and generating inflammatory cytokines that recruit immune cells to the joint. In this paper we profile cytokine secretion by primary human SFs from healthy tissues and from donors with RA...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Jenney, Anne P, Swantek, Jennifer L, Burke, John M, Sorger, Peter K, Jones II, Douglas S., Lauffenburger, Douglas A
Beste egile batzuk: Massachusetts Institute of Technology. Department of Biological Engineering
Formatua: Artikulua
Argitaratua: Springer Nature 2018
Sarrera elektronikoa:http://hdl.handle.net/1721.1/117697
https://orcid.org/0000-0002-0050-989X

Internet

http://hdl.handle.net/1721.1/117697
https://orcid.org/0000-0002-0050-989X

Antzeko izenburuak